BioNano Genomics appoints Terry Salyer as chief commercial officer

26 March 2015

Genome mapping specialist BioNano Genomics has appointed Terry Salyer as chief commercial officer.

Ms Salyer has more than 20 years experience of building effective worldwide sales teams in life sciences. At BioNano, Ms Salyer will oversee the commercialization of BioNano’s genome-mapping platform Irys System. At present, 32 institutions in the USA, Europe and Asia-Pacific already own an Irys System and BioNano recently expanded its existing Asia-Pacific distribution to Japan.

Before joining BioNano Genomics, Ms Salyer was vice president of worldwide sales at ProteinSimple.

This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Try before you buy

Free

7 day trial access

Take a Free Trial

All the news that moves the needle in pharma and biotech
Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
Receive The Pharma Letter daily news bulletin, free forever.

Become a subscriber

£820

Or £77 per month

Subscribe Now

Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
Daily roundup of key events in pharma and biotech.
Monthly in-depth briefings on Boardroom appointments and M&A news.
Choose from a cost-effective annual package or a flexible monthly subscription

The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK